First Review of Current Product and Procedure to be used in the Planned Global Phase 3 TrialNEW YORK, Jan. 11, 2016 -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of...

read more